ENGN: enGene Therapeutics Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

enGene Therapeutics Inc.

NASDAQ:ENGN

SummaryFactSheetFinancial
Price
$1.64
Loss Chance
58.9%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Related
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.84
37.56%
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.84
37.56%
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.36
$31.27
42.83%
Exelixis
NASDAQ:EXEL
6.93
$52.70
30.30%
Fabien Corp.
NASDAQ:FBIO
1.90
$0.13
100.00%
Jitta Factors
Growth Opportunity (1)
Recent Business Performance (17)
Financial Strength (34)
Return to Shareholders (0)
Competitive Advantage (1)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 113.34% in the last year
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
2.22
132.29%
3.06
159.05%
Biotechnology
5.68
37.56%
5.68
37.56%
6.36
42.83%
COMPANY DESCRIPTION
enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.
www.engene.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.